Analysts, along with MedaCorp Specialist Dr. Scott Gottlieb, discuss overturning the Chevron Deference and what areas of biopharma might be most impacted on an Analyst/Industry conference call to be held on July 15 at 10 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVX:
- Chevron price target lowered to $180 from $195 at Scotiabank
- FTC delays decision on Hess takeover by Chevron, Bloomberg reports
- FTC delays Chevron-Hess decision after Exxon arbitration, Bloomberg says
- Berkshire Hathaway Stock (NYSE:BRK.B): How Much Higher Can It Go?
- Jefferies energy analysts hold an analyst/industry conference call